Skip to main content
Clinical Trials/KCT0004587
KCT0004587
Completed
未知

A 12 weeks, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Angelica gigas N. extract powder(Nutragen) on joint health

Wonkwang University Oriental Medical Hospital, Jeonju0 sites80 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Wonkwang University Oriental Medical Hospital, Jeonju
Enrollment
80
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional Study
Sex
All

Investigators

Sponsor
Wonkwang University Oriental Medical Hospital, Jeonju

Eligibility Criteria

Inclusion Criteria

  • 1\) Males and females aged 50\-80 years at the screening examination
  • 2\) Participants currently with one or both knees pain
  • 3\) Participants with 1\~2 of Kellgren Lawrence grade(KL grade)
  • 4\) Participants who have fully understand the information provided about the study voluntarily decided to participate and agree to comply with precautions

Exclusion Criteria

  • 1\) Patients with a clinically significant disease requiring treatment (i.e., severe cardiovascular system, endocrine system, immune system, respiratory system, hepatobiliary system, kidney and urinary system, neuropsychiatric system, musculoskeletal inflammation, inflammatory disease, blood and tumor disease, gastrointestinal disease, etc.)
  • 2\) Patients who take medicine for joint health and intake health functional food within a month prior to the screening examination
  • 3\) Patients with a history of antipsychotic medication use within 2 months prior to the screening examination
  • 4\)Patients who have participated in other clinical trials within 3 months prior to the screening examination
  • 5\)Patients who are judged ineligible to participate in the trial by the principal investigator for other reasons, including laboratory test outcomes

Outcomes

Primary Outcomes

Not specified

Similar Trials